First Author n Study Group Overall Score (SD) Phys Fxn Phys Role Body Pain Gen'l Hlth Vitality Social Fxn Emot Role Mental Hlth PHC MHC
Schaefer (SF-36)[@95748] 68 All
39 Female 73.0 86.0 81.0 79.0 59.0 54.0 78.0 77.0 67.0 72.0 67.0
29 Male 81.0 90.0 90.0 88.0 67.0 55.0 84.0 97.0 75.0 78.0 75.0
38 WD-HEP 77.0 91.0 86.0 81.0 65.0 54.0 81.0 87.0 73.0 75.0 72.0
7 WD- NEURO 61.0 61.0 68.0 60.0 49.0 51.0 66.0 67.0 64.0 58.0 59.0
36 PEN 81.0 93.0 92.0 90.0 67.0 57.0 83.0 91.0 75.0 80.0 75.0
16 TRI 70.0 78.0 78.0 76.0 59.0 49.0 81.0 73.0 68.0 68.0 66.0
13 Zinc 67.0 81.0 71.0 70.0 54.0 50.0 74.0 79.0 58.0 65.0 63.0
Carta (SF-12)[@95749] 23 Cases 33.76 (9.0)
92 Controls 38.14 (6.4)
Svetel (SF-36)[@95750] 60 All 71.1 (24.8) 81.1 (26.8) 68.8 (41.3) 77.1 (31.7) 58.9 (26.1) 62.9 (27.9) 75.4 (29.2) 77.8 (37.7) 67.1 (26.2) 69.7 (25.1) 68.4 (25.1)
19 WD-HEP 81.5 (13.4) 92.4 (10.3) 90.8 (25.3) 77.1 (17.0) 80.0 (15.9) 77.7 (15.8)
41 WD- NEURO 66.3 (27.4) 75.8 (30.4) 58.5 (43.5) 62.4 (28.5) 65.0 (27.2) 64.1 (27.5)
Sutcliffe (SF-36)[@95751] 18 All 47.0 (11.0) 51 (10.0)
12 Female 43.0 (12.0) 48.0 (11.0)
6 Male 54.0 (4.0) 57 (5.0)
11 Acute LF 46.0 (13.0) 47.0 (10.0)
5 Chronic LF 44.0 (9.0) 58.0 (5.0)
2 Subacute LF 55.0 (3.0) 57.0 (5.0)
5 Major AE 44.0 (12.0) 54.0 (2.0)
13 No major AE 48.0 (11.0) 50.0 (12.0)
Camarata (SF-12)[@95754] 62 All 55.7 (50- 58.4) 50.1 (41.7- 56.9)
47 NEURO 55.63 (47.9- 58.38) 50.04 (41.71- 57.28)
11 No NEURO 56.90 (54.35- 58.6) 52.49 (35.28- 55.22)
Camarata (SF-12)[@95754] 27 Cognitive impairment 53.78 (49.74- 58.38) 50.00 (40.86- 56.92)
28 No cognitive impairment 57.01 (53.02- 58.49) 51.08 (42.37- 55.06)
12 Cirrhosis 55.66 (53.58- 57.61) 54.72 (51.23- 58.76)
26 No cirrhosis 55.48 (47.9- 58.60) 45.96 (39.89- 55.22)
22 Lifetime MDD 54.03 (44.96- 57.48) 42.85 (36.33- 52.80)
35 No lifetime MDD 56.31 (53.37- 58.38) 52.65 (44.97- 57.28)
33 Male 55.63 (53.56- 58.38) 46.52 (36.33- 54.93)
25 Female 54.59 (44.84- 56.92) 54.59 (44.84- 56.92)